S Gavasso

Summary

Affiliation: Haukeland University Hospital
Country: Norway

Publications

  1. ncbi request reprint Fcgamma receptor IIIA polymorphism as a risk-factor for coronary artery disease
    Sonia Gavasso
    Department of Clinical Medicine, Section for Neurology, University of Bergen and Haukeland University Hospital, N 5021 Bergen, Norway
    Atherosclerosis 180:277-82. 2005
  2. ncbi request reprint Multiplexed phosphoprotein analysis in immune cells
    S Gavasso
    Department of Clinical Medicine, Section of Neurology, University of Bergen and Haukeland University Hospital, Norway
    Acta Neurol Scand Suppl 183:58-60. 2006
  3. ncbi request reprint Long term use of oral contraceptives without thrombosis in patients with FV Leiden polymorphism: a study of 37 patients (2 homozygous and 35 heterozygous)
    A Girolami
    University of Padua Medical School, Department of Medical and Surgical Sciences, Second Chair of Medicine, Padua, Italy
    J Thromb Thrombolysis 17:145-9. 2004

Collaborators

Detail Information

Publications3

  1. ncbi request reprint Fcgamma receptor IIIA polymorphism as a risk-factor for coronary artery disease
    Sonia Gavasso
    Department of Clinical Medicine, Section for Neurology, University of Bergen and Haukeland University Hospital, N 5021 Bergen, Norway
    Atherosclerosis 180:277-82. 2005
    ..We have assessed the relationship between polymorphisms in three different FcgammaR genes and coronary artery disease (CAD)...
  2. ncbi request reprint Multiplexed phosphoprotein analysis in immune cells
    S Gavasso
    Department of Clinical Medicine, Section of Neurology, University of Bergen and Haukeland University Hospital, Norway
    Acta Neurol Scand Suppl 183:58-60. 2006
    ..Multiplexed phosphoprotein analysis will potentially incorporate environmental factors such as toxins or pathogens and genetic variability of individual patients in a step towards personalized medicine...
  3. ncbi request reprint Long term use of oral contraceptives without thrombosis in patients with FV Leiden polymorphism: a study of 37 patients (2 homozygous and 35 heterozygous)
    A Girolami
    University of Padua Medical School, Department of Medical and Surgical Sciences, Second Chair of Medicine, Padua, Italy
    J Thromb Thrombolysis 17:145-9. 2004
    ..Unfortunately so far there is no sure way to distinguish the women with this polymorphism who will develop venous thrombosis from those who will remain asymptomatic during oral contraceptive therapy...